Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Regenerative Medicine
Filter     Order     Display # 
Date Item Title Hits
26 Aug 2010 FibroGen Announces Results of 2-Year Study Demonstrating that Biosynthetic Corneas Formulated with Recombinant Human Type III Collagen Restore Vision and Promote Nerve Regeneration 5
17 Aug 2010 Life Technologies Announces Agreement to Acquire Ion Torrent 9
31 Jul 2010 Geron to Proceed with First Human Clinical Trial of Embryonic Stem Cell-Based Therapy 12
27 Jul 2010 Cytori Gains Stem Cell Device Approval in Europe for Breast Cancer Reconstruction and Soft Tissue Repair 10
07 Jul 2010 BioMimetic Therapeutics, Inc. Releases Clinical Update Including Positive 52-Week Data from North American Pivotal Trial 179
16 Jun 2010 Positive Data From Study of the AutoloGel System to Treat Complex Chronic Wounds Published in Ostomy Wound Management 226
01 Jun 2010 RepRegen Reports Data from an In Vivo Study of StronBone Bone Graft Substitute — The First Product from the Company’s Platform to Repair and Regenerate Hard Tissue, Such as Bone 312
30 Apr 2010 MESOBLAST COMPLETES ENROLMENT FOR FIRST SPINAL FUSION TRIAL 259
17 Mar 2010 TiGenix reports on regulatory path for ChondroCelect in the US 432
16 Mar 2010 Spinal Restoration Initiates Patient Enrollment for Phase III Study of Company's Biostat System 61
09 Mar 2010 BioMimetic Therapeutics Presents Promising Pre-Clinical Sports Medicine Data at the 2010 ORS Meeting 158
08 Mar 2010 Acologix Presents Data on Cartilage Regeneration by AC-100 at the 56th Annual Meeting of the Orthopaedic Research Society 54
29 Jan 2010 UT-Battelle Licenses Tissue-regeneration Technologies to NellOne Therapeutics; Advances ORNL Spin-out on Commercialization Path 522
07 Jan 2010 BioMimetic Therapeutics Strengthens its Agreement with Novartis for Exclusive Supply of rhPDGF-BB 581
07 Jan 2010 BioMimetic Therapeutics Strengthens its Agreement with Novartis for Exclusive Supply of rhPDGF-BB 84
14 Oct 2009 Study Shows Benefits of Medtronic's INFUSE® Bone Graft in Dental Restoration 859
13 Oct 2009 BioMimetic Therapeutics Announces Positive Top-Line Data from its Augment(TM) Bone Graft North American Pivotal Trial 460
14 Sep 2009 Scientific Journal Gene Therapy Reports That Cardium's Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration 958
10 Sep 2009 MESOBLAST'S PROPRIETARY STEM CELLS SUCCESSFULLY REPAIR/REGENERATE DAMAGED INTERVERTEBRAL DISC CARTILAGE 544
17 Aug 2009 Mesoblast Limited (ASX:MSB) Gains US FDA Clearance For Phase 2 Trial Of NeoFuse In Minimally Invasive Lumbar Spinal Fusion Surgery 778
10 Aug 2009 Compassionate Use Patients in Spain Treated With Adult Stem Cell Therapy Demonstrate Jaw Bone Regeneration Enabling Dental Implants 540
07 Aug 2009 Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 507
07 Aug 2009 Cytomedix Files Application With FDA for AutoloGel(tm) System in Orthopedics 483
26 Jun 2009 TiGenix receives positive CHMP opinion on European MAA for ChondroCelect 828
17 Jun 2009 BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 512
21 Aug 2008 Mesoblast's allogenic, "off the shelf", stem cells are safe and effective for cervical spine fusion 828
11 Aug 2008 Kuros Biosurgery AG Announces Results Of ONE-Month Follow-Up Of Phase IIa Trial of KUR-212 in Patients with Burns requiring Mesh Grafting; KUR-212 Meets Phase IIa Trial Primary Endpoint 660
28 Jul 2008 Nuvelo Initiates Phase 1 Clinical Trial of NU206 in Healthy Volunteers 722
18 May 2008 Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder with Tengion Neo-Bladder Replacement(TM) 763
16 Apr 2008 12 Month Analysis of Juvista Clinical Trials 0050 and 0036 867
 
<< Start < Prev 1 2 3 4 5 6 Next > End >>
Results 1 - 30 of 173

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease

Order Now

Recommended Report

R&D Drug Pipeline Database
Order Now

Subscribe La Merie Biologics